Sector › Medicine
Press Releases
Eisai: "LEQEMBI" (Lecanemab) Approved for the Treatment of Alzheimer's Disease in China
Eisai
Jan 10, 2024 09:15 HKT/SGT
Transgene and NEC Extend their Collaboration to Continue Joint Clinical Development of Neoantigen Cancer Vaccine TG4050
NEC Corporation
Jan 09, 2024 15:30 HKT/SGT
BYND Cannasoft Enterprises Inc. Announces Receipt of Nasdaq Minimum Bid Price Notification
Femto Technologies Inc
Jan 09, 2024 09:00 HKT/SGT
Nutrigene Launches Personalised Development Program to Intersect Genetics and Learning through DNA
Nutrigene Modern Sciences Sdn. Bhd
Jan 08, 2024 13:00 HKT/SGT
Spiden Announces Breakthrough in Non-Invasive Glucose Monitoring, Adds Key Executive Hires and Secures $15m in Additional Funding
Spiden
Jan 06, 2024 09:00 HKT/SGT
CMS(00867) Joins Hands with Pharmaron to Promote the Singapore Manufacturing Plant Acquisition and CDMO Business in SEA
China Medical System Holdings Ltd.
Jan 02, 2024 15:00 JST
CMS(00867) Joins Hands with Pharmaron to Promote the Singapore Manufacturing Plant Acquisition and CDMO Business in SEA
China Medical System Holdings Ltd.
Jan 02, 2024 14:00 HKT/SGT
Development of Prediction Model for Brain Amyloid-Beta Accumulation Using Wristband Sensor
Eisai
Dec 29, 2023 13:30 HKT/SGT
Rotary Action Group Taps Drug Free Australia to Represent Oceania on a Global Stage
Baden Bower
Dec 24, 2023 11:39 HKT/SGT
BYND Cannasoft Enterprises Inc. Announces Leadership Change in Its Subsidiary BYND - Beyond Solutions Ltd. ("BYND")
Femto Technologies Inc
Dec 23, 2023 07:00 HKT/SGT
BioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Research
BioMed X Institute
Dec 22, 2023 09:00 HKT/SGT
BYND Cannasoft Announces Closing of US$1.5 Million Registered Direct Offering
Femto Technologies Inc
Dec 21, 2023 23:07 HKT/SGT
